TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
安妮塔· G.
2 个月前
伊姆兰 F.
2 周前
扎伊纳布 N.
1 周前
尤素夫·A.
1 个月前
